Search stocks

Find any stock by ticker or company name

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

О нас

Контакты

[email protected]

Мы в соцсетях

Instagram
Telegram
LinkedIn

Все права защищены.

Условия использования

Главная
Избранное
Рынки
Скринер
Новости
О нас

KIDS - OrthoPediatrics Corp. Последние новости | Finranks

Home

/

KIDS

O

OrthoPediatrics Corp. (KIDS)

NGM – Цена в реальном времени. Валюта: USD

17.72

+0.54 (3.14%)

При закрытии: May 12, 2026, 4:00 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

OrthoPediatrics Corp. (KIDS) Q1 2026 Earnings Call Transcript

OrthoPediatrics Corp. (KIDS) Q1 2026 Earnings Call Transcript

OrthoPediatrics Corp. (KIDS) Q1 2026 Earnings Call Transcript

OrthoPediatrics (KIDS) Reports Q1 Earnings: What Key Metrics Have to Say

OrthoPediatrics (KIDS) Reports Q1 Earnings: What Key Metrics Have to Say

The headline numbers for OrthoPediatrics (KIDS) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

OrthoPediatrics Corp. to Report First Quarter Financial Results on April 30, 2026

OrthoPediatrics Corp. to Report First Quarter Financial Results on April 30, 2026

WARSAW, Ind., April 16, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its first quarter 2026 financial results on Thursday, April 30, 2026 after the market closes.

OrthoPediatrics to Participate in the 25th Annual Needham Virtual Healthcare Conference

OrthoPediatrics to Participate in the 25th Annual Needham Virtual Healthcare Conference

WARSAW, Ind., March 31, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer, and Chief Financial Officer, are scheduled to participate in a fireside chat at the 25th Annual Needham Virtual Healthcare Conference.

Wall Street Analysts Predict a 51.12% Upside in OrthoPediatrics (KIDS): Here's What You Should Know

Wall Street Analysts Predict a 51.12% Upside in OrthoPediatrics (KIDS): Here's What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 51.1% in OrthoPediatrics (KIDS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

OrthoPediatrics (KIDS) Upgraded to Buy: What Does It Mean for the Stock?

OrthoPediatrics (KIDS) Upgraded to Buy: What Does It Mean for the Stock?

OrthoPediatrics (KIDS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Wall Street Analysts See a 32.67% Upside in OrthoPediatrics (KIDS): Can the Stock Really Move This High?

Wall Street Analysts See a 32.67% Upside in OrthoPediatrics (KIDS): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 32.7% in OrthoPediatrics (KIDS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Видео

No Data

There is no data to display

Пресс-релизы

OrthoPediatrics to Participate in the 25th Annual Needham Virtual Healthcare Conference

OrthoPediatrics to Participate in the 25th Annual Needham Virtual Healthcare Conference

WARSAW, Ind., March 31, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer, and Chief Financial Officer, are scheduled to participate in a fireside chat at the 25th Annual Needham Virtual Healthcare Conference.

OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2025 Financial Results

OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2025 Financial Results

Record full year 2025 revenue of $236.3 million increased 15% compared to prior year Operating Cash flow improvement of $22 million in full year 2025 Generated $10 million of free cash flow in the fourth quarter, the first quarter of positive free cash flow in Company history WARSAW, Ind., Feb. 26, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the fourth quarter and full year ended December 31, 2025.

OrthoPediatrics Announces Expanded Enabling Technology Market Opportunity

OrthoPediatrics Announces Expanded Enabling Technology Market Opportunity

OrthoPediatrics partner iotaMotion receives FDA clearance for use of its iotaSOFT® cochlear implant insertion system in patients four years and older OrthoPediatrics partner iotaMotion receives FDA clearance for use of its iotaSOFT® cochlear implant insertion system in patients four years and older

OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2025 and Issues 2026 Financial Guidance

OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2025 and Issues 2026 Financial Guidance

Achieves all-time high full year 2025 Revenue of $236.1 million representing growth of 15% over prior year Initiates guidance for record Adjusted EBITDA in 2026